COBAS INTEGRA CREATININE PLUS VER.2 ASSAY

Enzymatic Method, Creatinine

ROCHE DIAGNOSTICS CORP.

The following data is part of a premarket notification filed by Roche Diagnostics Corp. with the FDA for Cobas Integra Creatinine Plus Ver.2 Assay.

Pre-market Notification Details

Device IDK024098
510k NumberK024098
Device Name:COBAS INTEGRA CREATININE PLUS VER.2 ASSAY
ClassificationEnzymatic Method, Creatinine
Applicant ROCHE DIAGNOSTICS CORP. 9115 HAGUE RD. Indianapolis,  IN  46250
ContactSherri L Coenen
CorrespondentSherri L Coenen
ROCHE DIAGNOSTICS CORP. 9115 HAGUE RD. Indianapolis,  IN  46250
Product CodeJFY  
CFR Regulation Number862.1225 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2002-12-12
Decision Date2002-12-19
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
07613336121160 K024098 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.